JP2023527059A5 - - Google Patents
Info
- Publication number
- JP2023527059A5 JP2023527059A5 JP2022573217A JP2022573217A JP2023527059A5 JP 2023527059 A5 JP2023527059 A5 JP 2023527059A5 JP 2022573217 A JP2022573217 A JP 2022573217A JP 2022573217 A JP2022573217 A JP 2022573217A JP 2023527059 A5 JP2023527059 A5 JP 2023527059A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- use according
- dmard
- weeks
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030065P | 2020-05-26 | 2020-05-26 | |
| US63/030,065 | 2020-05-26 | ||
| US202163155125P | 2021-03-01 | 2021-03-01 | |
| US63/155,125 | 2021-03-01 | ||
| EP21315087.3 | 2021-05-25 | ||
| EP21315087 | 2021-05-25 | ||
| PCT/IB2021/054546 WO2021240369A1 (en) | 2020-05-26 | 2021-05-25 | Compositions comprising an antibody against interleukin-6 receptor for the treatment of rheumatoid arthritis and methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527059A JP2023527059A (ja) | 2023-06-26 |
| JP2023527059A5 true JP2023527059A5 (enExample) | 2024-06-03 |
Family
ID=76197513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573217A Pending JP2023527059A (ja) | 2020-05-26 | 2021-05-25 | 関節リウマチを治療するためのインターロイキン６受容体に対する抗体を含む組成物およびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230174657A1 (enExample) |
| JP (1) | JP2023527059A (enExample) |
| AU (1) | AU2021281119A1 (enExample) |
| BR (1) | BR112022024020A2 (enExample) |
| CA (1) | CA3180369A1 (enExample) |
| IL (1) | IL298088A (enExample) |
| WO (1) | WO2021240369A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202111742QA (en) | 2019-04-24 | 2021-11-29 | Sanofi Biotechnology | Methods of diagnosis and treatment of rheumatoid arthritis |
| CA3142710A1 (en) | 2019-06-04 | 2020-12-10 | Sanofi Biotechnology | Compositions and methods for treating pain in subjects with rheumatoid arthritis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5215534A (en) | 1991-12-02 | 1993-06-01 | Lawrence De Harde | Safety syringe system |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| US8080248B2 (en) * | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
| JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| US9427531B2 (en) | 2010-06-28 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Auto-injector |
| US9248242B2 (en) | 2012-04-20 | 2016-02-02 | Safety Syringes, Inc. | Anti-needle stick safety device for injection device |
| US20140155827A1 (en) | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
| SG11202101674QA (en) * | 2018-08-29 | 2021-03-30 | Regeneron Pharma | Methods and compositions for treating subjects having rheumatoid arthritis |
-
2021
- 2021-05-25 CA CA3180369A patent/CA3180369A1/en active Pending
- 2021-05-25 BR BR112022024020A patent/BR112022024020A2/pt unknown
- 2021-05-25 US US17/926,018 patent/US20230174657A1/en active Pending
- 2021-05-25 AU AU2021281119A patent/AU2021281119A1/en active Pending
- 2021-05-25 IL IL298088A patent/IL298088A/en unknown
- 2021-05-25 WO PCT/IB2021/054546 patent/WO2021240369A1/en not_active Ceased
- 2021-05-25 JP JP2022573217A patent/JP2023527059A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069453A5 (enExample) | ||
| US11993605B2 (en) | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof | |
| US10202449B2 (en) | Cachexia treatment | |
| JP2022033891A (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| AU2011293554B2 (en) | Treatment for neoplastic diseases | |
| US11512092B2 (en) | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof | |
| JP2018515493A5 (enExample) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| JP2022502350A5 (enExample) | ||
| JP2023527059A5 (enExample) | ||
| JP2022534794A5 (enExample) | ||
| JP2020045351A (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| JP2025134820A (ja) | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 | |
| JP2022530063A (ja) | 抗体製剤 | |
| WO2021018191A1 (zh) | Il-17拮抗剂治疗自身免疫疾病的方法 | |
| WO2025181224A1 (en) | Cd19-selective t cell engaging molecule for treating autoimmune diseases/ autoimmune conditions | |
| WO2024077113A1 (en) | Methods of treating fatigue in ulcerative colitis | |
| WO2025257781A1 (en) | Treatment of systemic sclerosis using anti-baff-r antibodies | |
| AU2024304477A1 (en) | Use of recombinant anti-interleukin 23p19 subunit antibody in treating inflammatory bowel disease | |
| TW202302146A (zh) | 使用抗baffr抗體治療全身性紅斑狼瘡 | |
| HK1199616B (en) | Cachexia treatment |